Jorge Villafañe | Medicine | Best Researcher Award

Published on by Plant Scientist

Prof. Dr. Jorge Villafañe | Medicine | Best Researcher Award

Universidad Europea de Madrid | Spain

Author Profile

Scopus
Orcid ID
Google Scholar

JORGE HUGO VILLAFAÑE, PhD: A PIONEER IN MUSCULOSKELETAL REHABILITATION 🌟

INTRODUCTION

Dr. Jorge Hugo Villafañe is a distinguished researcher, clinician, and academician renowned for his contributions to musculoskeletal rehabilitation. With a Ph.D. from the Universidad Rey Juan Carlos, Spain, and an extensive professional career spanning over two decades, he has significantly influenced physiotherapy and rehabilitation sciences. His prolific research, boasting over 300 indexed publications, has transformed therapeutic approaches worldwide.

📚 EARLY ACADEMIC PURSUITS

Dr. Villafañe began his academic journey with a Bachelor’s degree in Kinesiology and Physiotherapy from the Universidad Nacional de Córdoba, Argentina (2001). His quest for knowledge led him to pursue a Master’s in Manual Therapy at the Universidad Europea de Madrid (2009). In 2012, he completed his Ph.D. in Physiotherapy at Universidad Rey Juan Carlos, where his exceptional research earned him the “Premio Extraordinario” (2014).

🧪 PROFESSIONAL ENDEAVORS

His professional career is marked by influential roles in both clinical and academic settings. Some key positions include:

  • Senior Researcher at IRCCS Instituto Ortopédico Galeazzi, Milan, Italy (2015-2019).
  • Senior Researcher at the Don Carlo Gnocchi Foundation, Milan, Italy (2013-2024).
  • Private Physiotherapy Practice in Italy (2003-Present).
  • Professor at Universidad Europea de Madrid, Spain.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Medicine

Dr. Villafañe’s research primarily focuses on musculoskeletal rehabilitation, particularly in physiotherapy interventions for chronic pain, biomechanics, and innovative rehabilitation techniques. His findings have been instrumental in shaping rehabilitation protocols and clinical practices.

  • Advanced manual therapy techniques
  • Rehabilitation approaches for musculoskeletal disorders
  • Clinical biomechanics in physiotherapy
  • Integrative pain management strategies

His participation in high-impact scientific projects, including Horizon 2020 initiatives, has solidified his status as a thought leader in physiotherapy.

🌍 IMPACT AND INFLUENCE

Dr. Villafañe’s research has significantly impacted clinical physiotherapy and rehabilitation sciences. His work has not only guided treatment methodologies but also influenced policies and training programs worldwide. As a mentor, he has shaped the next generation of physiotherapists, fostering advancements in patient-centered therapeutic approaches.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Villafañe’s scholarly impact is reflected in:

  • Over 300 scientific publications in indexed journals.
  • h-index of 43 (ISI Web of Science), demonstrating high citation rates and influence.
  • Numerous book chapters and conference presentations.

His publications, frequently appearing in high-impact journals, are widely cited by researchers and clinicians alike.

🏅 HONORS & AWARDS

  • “Premio Extraordinario” for Ph.D. (2014).
  • Abilitazione Scientifica Nazionale (ASN), Italy (2017).
  • Best Basic Research Poster Award, John H. Moe, Bologna (2018).
  • National Congress Award (AISD, 2011).
  • Knight of the Royal Maestranza de Castilla, Spain.

🌐 LEGACY AND FUTURE CONTRIBUTIONS

With an ever-expanding research portfolio and commitment to innovation in physiotherapy, Dr. Villafañe’s future endeavors promise to further enhance rehabilitation sciences and patient outcomes. His work remains a cornerstone in the global advancement of musculoskeletal physiotherapy.

🌠 FINAL NOTE

Dr. Villafañe’s dedication to research, clinical excellence, and academic leadership has left an indelible mark on musculoskeletal rehabilitation. His pioneering work continues to influence the field, setting new standards for patient care and therapeutic advancements.

📑 NOTABLE PUBLICATIONS 

Impact of the 1742–1743 Plague Epidemic on Global Excess Deaths and Social Dynamics in the City of Santa Fe and Along the Royal Road Between Buenos Aires and Lima
  • Author: Jorge Hugo Villafañe
  • Journal: Genealogy
  • Year: 2025
Demographic and Genetic Impact of the 1742–1743 Plague Epidemic in Córdoba, Argentina: A Bioanthropological Perspective
  • Author: Jorge Hugo Villafañe
  • Journal: Histories
  • Year: 2025
Impact of the 1742–1743 Plague Epidemic on Global Excess Deaths and Social Dynamics in the City of Córdoba and Along the Camino Real Between Buenos Aires and Lima
  • Author: Jorge Hugo Villafañe
  • Journal: Societies
  • Year: 2025
Effects of Hippotherapy and Horse-Riding Simulators on Gross Motor Function in Children with Cerebral Palsy: A Systematic Review
  • Authors: Antonio Ortega-Cruz, Víctor Sánchez-Silverio, Víctor Riquelme-Aguado, Jose Luis Alonso-Perez, Vanesa Abuín-Porras, Jorge Hugo Villafañe
  • Journal: Journal of Clinical Medicine
  • Year: 2025
Exercise Intervention in Women with Fibromyalgia and Its Influence on Pain, Psychological Variables, and Disability: An Observational Study
  • Authors: María Elena González-Álvarez, Víctor Riquelme-Aguado, Giacomo Rossettini, Josué Fernández-Carnero, Jorge Hugo Villafañe
  • Journal: Life
  • Year: 2024

 

Boris Timah Acha | Medicinal Plants | Best Researcher Award

Published on by Plant Scientist

Mr. Boris Timah Acha | Medicinal Plants | Best Researcher Award

Universidade Federal do Piaui | Brazil

Author Profile

Orcid ID

INTRODUCTION

Boris Timah Acha is a Brazilian pharmacologist specializing in clinical analysis, pharmaceutical attention, and the pre-clinical pharmacology and toxicology of natural and synthetic products. He holds a Bachelor’s degree in Pharmacy from the Federal University of Piauí (UFPI) and a Master’s degree in Pharmacology from the same institution. His expertise lies in the prospecting of bioactive molecules for the treatment of pain and inflammation, focusing on the effects of chemotherapy-induced neuropathy.

📚 EARLY ACADEMIC PURSUITS

Boris started his academic journey in pharmacy, graduating from the Federal University of Piauí in 2019. During his undergraduate studies, he was involved in scientific initiation projects that led to research on the analgesic effects of various molecules in neuropathic pain. His early academic interests centered around pharmacology, chemistry, and phytochemistry.

🧪 PROFESSIONAL ENDEAVORS

Upon completing his Bachelor’s degree, Boris advanced to a Master’s program in Pharmacology at UFPI. His research during this period focused on evaluating the antinociceptive activity and mechanisms of action of Terpinolene in animal models of neuropathic pain induced by chemotherapy. Additionally, he has contributed to various clinical pharmacy internships and has worked as a preceptor in compulsory internships as per Brazilian law.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Medicinal Plants

Boris’s research emphasizes the exploration of natural and synthetic molecules for their potential therapeutic benefits in pain and inflammation. He has investigated the pharmacological effects of gamma-terpinene and alpha-felandrene in animal models, contributing significantly to the understanding of their mechanisms in alleviating chemotherapy-induced pain.

🌍 IMPACT AND INFLUENCE

Through his research, Boris has provided valuable insights into the molecular mechanisms underlying neuropathic pain and inflammation. His work is important for the development of more effective pain treatments, especially for patients undergoing chemotherapy. His contributions extend to clinical applications, where he has worked to improve pharmaceutical care in pharmacies.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

Boris has published his findings in academic journals and presented them at various national conferences. His research on bioactive molecules and pharmacology has garnered attention from professionals in the fields of pharmacology, toxicology, and clinical pharmacy.

🏅 HONORS & AWARDS

Boris has received several prestigious awards, including scholarships from the Coordination for the Improvement of Higher Education Personnel (CAPES). He was also a recipient of a scientific initiation grant during his undergraduate years, allowing him to further explore his research interests.

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Boris’s future work is poised to significantly impact pharmacology and clinical pharmacy, particularly in the discovery of novel bioactive molecules and the application of pharmacological research to improve patient care. He is committed to furthering his studies in clinical and hospital pharmacy, while continuing his pharmacological research.

🌠 FINAL NOTE

Boris Timah Acha continues to contribute to the fields of pharmacology and pharmaceutical sciences, working towards the discovery of new therapeutic agents for pain management. His dedication to advancing scientific knowledge and improving clinical practices marks him as an emerging leader in his field.

📑 NOTABLE PUBLICATIONS 

Anti-Hyperalgesic Effect of Isopulegol Involves GABA and NMDA Receptors in a Paclitaxel-Induced Neuropathic Pain Model
  • Journal: Pharmaceuticals
  • Year: 2025-02-14
  • Authors: Deyna Martins, Boris Acha, Mickael Cavalcante, Suellen Pereira, Ana Viana, Flaviano Ribeiro Pinheiro-Neto, Priscyla Mendes, Dalton Dittz-Júnior, Francisco Oliveira, Tatiana Ventura et al.
Promising Effects of Casearins in Tumor-Bearing Mice and Antinociceptive Action against Oncologic Pain: Molecular Docking and In Vivo Findings
  • Journal: Pharmaceuticals
  • Year: 2024-05-14
  • Authors: Jurandy do Nascimento Silva, José Ivo Araújo Beserra Filho, Boris Timah Acha, Fernanda Regina de Castro Almeida, Emanuelle Karine Frota Batista, Valdenizia Rodrigues Silva, Larissa Mendes Bomfim, Milena Botelho Pereira Soares, Daniel Pereira Bezerra, André Gonzaga dos Santos et al.
The Isopropyl Gallate Counteracts Cyclophosphamide-Induced Hemorrhagic Cystitis in Mice
  • Journal: Biology
  • Year: 2022-05-09
  • Authors: Lucas Solyano Almeida de Oliveira, Sara Raquel de Moura Bandeira, Rodrigo Lopes Gomes Gonçalves, Benedito Pereira de Sousa Neto, Diana Carvalho de Rezende, Antonio Carlos dos Reis-Filho, Ian Jhemes Oliveira Sousa, Flaviano Ribeiro Pinheiro-Neto, Boris Timah Acha, Gabriela do Nascimento Caldas Trindade et al.
Impacto epidemiológico da dengue no estado da Paraíba, Brasil
  • Journal: Research, Society and Development
  • Year: 2019-11-01
  • Authors: Evaldo Hipólito Oliveira, Jôslanne dos Santos Soares, Boris Timah Acha, Roseane Mara CardosoLima Verde, Leonardo Ferreira Soares, Hildeneide Rocha Lima

 

 

Hala Al Daghistani | Medicinal Plants | Best Researcher Award

Published on by Plant Scientist

Prof. Hala Al Daghistani | Medicinal Plants | Best Researcher Award

Al Ahliyya Amman University | Best Researcher Award

Author Profile

Scopus
Orcid ID

 🌟HALA IBRAHIM AL-DAGHISTANI: PIONEER IN MEDICAL MICROBIOLOGY AND IMMUNOLOGY

INTRODUCTION

Hala Ibrahim Al-Daghistani, an esteemed academic from Iraq, holds the position of Associate Professor in Medical Microbiology and Immunology. With over two decades of expertise, her contributions to the field of medical microbiology, particularly in infertility and microbial pathogenesis, have left a significant mark. Based in Amman, Jordan, her academic and research career spans renowned institutions and offers invaluable insights into microbial resistance and its role in health.

📚 EARLY ACADEMIC PURSUITS

Dr. Al-Daghistani’s academic journey began at the University of Jordan, where she earned her B.Sc. in Medical Analysis (1987). She later pursued a M.Sc. in Medical Microbiology, focusing on Toxigenicity and Penicillin resistance in Staphylococcus aureus. Her keen interest in the intersection of immunology and microbiology led her to the University of Baghdad, where she completed a Ph.D. (1998), studying the bacteriological and immunological factors contributing to infertility in women.

🧪 PROFESSIONAL ENDEAVORS

Over the years, Dr. Al-Daghistani has amassed invaluable experience in teaching and clinical laboratory settings. Her professional history includes notable teaching roles in undergraduate and graduate courses, such as Microbiology, Immunology, and Diagnostic Microbiology. Her clinical expertise covers molecular genetics, infertility investigations, and microbial diagnostics. Additionally, she has mentored several postgraduate students and played pivotal roles in various academic and research committees.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Medicinal Plants 

Dr. Al-Daghistani’s research has significantly contributed to the understanding of bacterial pathogenesis, antibiotic resistance, and microbial epidemiology, particularly in infertility studies. Her work in detecting and analyzing Staphylococcus aureus and Chlamydia trachomatis has led to essential findings in microbial resistance patterns and clinical diagnostics. She has also focused on the biotechnological potential of halophilic bacteria from the Dead Sea.

🌍 IMPACT AND INFLUENCE

Her work has greatly influenced the field of medical microbiology, particularly in the context of infertility and microbial resistance. Through her dedication to academia and research, Dr. Al-Daghistani has played a crucial role in developing modern diagnostic and treatment methods for infections associated with infertility. Her collaborations with international and local agencies, such as the UNDP and Arab Potash Company, further highlight her global impact.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Al-Daghistani has an extensive publication record, contributing numerous research articles to international journals. She has also secured several research grants to further her studies on microbial resistance and infertility. Her scholarly works on Mycoplasma hominis, Ureaplasma urealyticum, and other microbial pathogens have earned her recognition within the academic community.

🏅 HONORS & AWARDS

  • The Scientific Award for Applied Sciences (Hisham Hijjawi, 2001)
  • Excellence Award for Supervising the Best Master’s Thesis (2023)
  • Research Grants from institutions such as Arab Potash Company and Al-Balqa Applied University

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Al-Daghistani’s research on microbial pathogenesis and infertility continues to promise significant breakthroughs. Her commitment to education, research, and community engagement positions her as a leading figure in the fields of microbiology and immunology.

🌠 FINAL NOTE

Dr. Al-Daghistani’s career is a testament to the power of dedication, hard work, and academic excellence. She continues to influence the future of medical microbiology through her innovative research, shaping the next generation of scholars in her field.

📑 NOTABLE PUBLICATIONS 

Quorum Quenching of P. aeruginosa by Portulaca oleracea Methanolic Extract and Its Phytochemical Profile
  • Journal: Pathogens
  • Year: 2025
  • Authors: Hala Al-Daghistani, Sina M. Matalqah, Khalid Shadid, Lubna Abu-Niaaj, Sima Zein, Raeda M. Abo-Ali
Genetic Signature and Serocompatibility Evidence for Drug Resistant Campylobacter jejuni
  • Journal: Antibiotics
  • Year: 2022
  • Authors: Rozan O. Al-Khresieh, Hala Al-Daghistani, Saeid Abu-Romman, Lubna Abu-Niaaj
Isolation and characterization of thermophilic bacteria from Jordanian hot springs: Bacillus licheniformis and Thermomonas hydrothermalis isolates are potential producers of thermostable enzymes
  • Journal: International Journal of Microbiology
  • Year: 2017
  • Authors: Balsam Mohammad, Hala Al-Daghistani, Atef Jouani, Christian Kennes, Saleh Abdel-Latif

 

Abduh Murshed | Biomedical Engineering | Best Researcher Award

Published on by Plant Scientist

Dr. Abduh Murshed | Biomedical Engineering | Best Researcher Award

Affiliated Hospital of Guangdong Medical University |China

Author Profile

Scopus

 🌟ABDUH MURSHED: PIONEERING RESEARCHER IN MEDICINAL PLANTS AND NANOMEDICINE

INTRODUCTION

Abduh Murshed is a distinguished Postdoctoral Researcher specializing in medicinal plants and nanomedicine at the Affiliated Hospital of Guangdong Medical University, China. With a strong academic background in Clinical Laboratory Diagnostics, he has made significant contributions to plant-derived exosome research and their potential in medical applications. His work is at the intersection of plant science and clinical research, providing groundbreaking insights into disease treatment strategies.

📚 EARLY ACADEMIC PURSUITS

Abduh Murshed earned his Ph.D. in Clinical Laboratory Diagnostics from Tongji University, Shanghai, in July 2022. During his doctoral studies, he focused on plant-based therapeutic strategies, particularly their role in translational medicine. His research delved into plant-derived exosomes with intrinsic reactive oxygen species (ROS)-scavenging ability and their impact on sepsis-induced NETosis.

🧪 PROFESSIONAL ENDEAVORS

Currently, Dr. Murshed is engaged in postdoctoral research at the Affiliated Hospital of Guangdong Medical University. His expertise spans in vitro and in vivo experimentation, purification of plant nanoparticles/exosomes, and assessing their toxicity and therapeutic potential. He is actively involved in ongoing research projects, collaborating with experts in plant sciences, nanomedicine, and clinical applications.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Biomedical Engineering

Dr. Murshed has completed 13 SCI-indexed research studies and has five additional manuscripts scheduled for submission within the next two months. His research primarily focuses on:

  • The isolation and characterization of plant-derived exosomes.
  • The therapeutic applications of plant nanoparticles for disease treatment.
  • The modulation of immune responses using plant-based compounds.
  • The development of innovative approaches for medicinal plant research.

🌍 IMPACT AND INFLUENCE

His work has significantly influenced the field of medicinal plants and nanomedicine, contributing to the understanding of plant-based therapies. By merging plant biology with clinical diagnostics, he has paved the way for novel treatments for inflammatory diseases and other medical conditions.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

  • Research Publications: 13 SCI-indexed journal papers.
  • Citation Index: 102 citations.
  • Consultancy/Industry Projects: 1 project.
  • Collaborations: Extensive collaboration in plant research, including in vitro and in vivo studies.

🏅 HONORS & AWARDS

Dr. Abduh Murshed has been recognized for his contributions to medicinal plant research and nanomedicine. His excellence in scientific innovation and translational medicine has positioned him as a key figure in his field. His research has been acknowledged at academic conferences and through peer-reviewed publications.

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Abduh Murshed’s research is poised to influence future advancements in plant-based nanomedicine. His dedication to scientific excellence ensures a lasting impact on both academic and clinical research. As he continues to publish groundbreaking studies and engage in innovative research, his contributions will remain invaluable to the global scientific community.

🌠 FINAL NOTE

With an unwavering commitment to advancing medicinal plant research, Dr. Murshed continues to explore novel therapeutic applications. His expertise in plant-derived nanoparticles and their medical relevance is driving innovation in translational medicine. His ongoing projects and collaborations signify his potential for future breakthroughs in nanomedicine and plant-based therapeutics.

📑 NOTABLE PUBLICATIONS 

 Abrogation of ORF8–IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches
  • Authors: M. Suleman, A. Murshed, K. Imran, H.M. Yassine, S. Crovella, et al.
    Journal: BMC Chemistry
    Year: 2024

 

Lina Chen | Plant Biotechnology | Best Researcher Award

Published on by Plant Scientist

Prof. Lina Chen | Plant Biotechnology | Best Researcher Award

School of Basic Medical Sciences, Xi’an Jiaotong University | China

Author Profile

Orcid ID

LINA CHEN: A LEADING EXPERT IN ENDOCRINE AND CARDIOVASCULAR PHARMACOLOGY 🌱

📚 EARLY ACADEMIC PURSUITS

Lina Chen began her academic journey in 1992 at Xi’an Medical University, where she pursued a Bachelor of Medicine in Preventive Medicine. Her commitment to pharmacology led her to Xi’an Jiaotong University, where she completed her MSc in Pharmacology (2003) and later, a PhD in the same field (2006). These formative years laid the foundation for her distinguished career in pharmacology and medical sciences.

🧪 PROFESSIONAL ENDEAVORS

After obtaining her PhD, Lina Chen worked as a Lecturer in the Department of Pharmacology at Xi’an Jiaotong University (2006-2013). Her academic journey continued with an Associate Professorship (2013-2017) and eventually to the position of Professor (2018-present). Her career was also enriched by an international collaboration as a Visiting Scholar at the University of Nebraska Medical Center in 2009-2010, strengthening her global research network.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PLANT BIOTECHNOLOGY

Professor Chen is renowned for her work in endocrine and cardiovascular pharmacology, specifically focusing on the pathogenesis, drug screening, prevention, and treatment of diabetes and metabolic diseases. She has led numerous high-profile research projects, including national programs such as the National Major New Drug Development Project and the National Natural Science Foundation of China. Her research has a significant impact on understanding and combating chronic diseases, particularly in the context of Chinese and global health challenges.

🌍 IMPACT AND INFLUENCE

Professor Chen’s groundbreaking work has influenced both academic research and practical healthcare solutions. She has contributed extensively to medical literature, with over 80 published articles, including 40 SCI papers. Her 7 national invention patents showcase her innovation in pharmacological treatments and drug development, cementing her reputation as a thought leader in her field. Her work is integral to the development of novel drugs and therapeutic strategies.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

With an impressive Citation Index of 831, Professor Chen’s research has been widely recognized within the scientific community. Her work has been published in top-tier journals and included in more than 40 books. Her contributions have earned her recognition as a key player in pharmacological research. Professor Chen has also been an editorial board member for several prestigious journals, influencing scientific publication and policy.

🏅 HONORS & AWARDS

  • Second Prize of Science and Technology Progress from Shaanxi Province
  • National Invention Patents (7 patents)
  • Various Research Grants and Fellowships, including those from the National Natural Science Foundation of China and the Provincial Key Projects.

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Professor Chen‘s career is characterized by her unwavering commitment to public health, groundbreaking research, and innovative contributions to pharmacology. Looking ahead, her ongoing research will continue to shape the landscape of diabetes treatment and cardiovascular health, providing new hope for millions worldwide. Her future contributions are expected to be instrumental in furthering both scientific discovery and the practical application of pharmacological therapies.

🌠 FINAL NOTE

Professor Lina Chen continues to advance the field of pharmacology with a focus on diabetes and cardiovascular diseases. Her research excellence and innovative drug developments promise to leave a lasting legacy in both academia and global healthcare. With a clear vision for the future, she remains a leading voice in the pursuit of medical solutions for metabolic diseases.

📑 NOTABLE PUBLICATIONS 

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis.
  • Journal: Molecular Medicine (Cambridge, Mass.)
  • Date: 2023-09-28
  • Authors: Guo T, Yan W, Cui X, Liu N, Wei X, Sun Y, Fan K, Liu J, Zhu Y, Wang Z et al.
Corrigendum to “Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice” [Cellular Signalling 106 (2023) 110614].
  • Journal: Cellular Signalling
  • Date: 2023-09-09
  • Authors: Yan W, Guo T, Liu N, Cui X, Wei X, Sun Y, Hu H, Chen L
Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice.
  • Journal: Cellular Signalling
  • Date: 2023-09-06
  • Authors: Yan W, Guo T, Liu N, Cui X, Wei X, Sun Y, Hu H, Chen L
Mollugin activates GLP-1R to improve cognitive dysfunction in type 2 diabetic mice.
  • Journal: Life Sciences
  • Date: 2023-08-21
  • Authors: Wang Z, Cui X, Yan W, Liu N, Shang J, Yi X, Guo T, Wei X, Sun Y, Hu H et al.
Schisandrin B, a potential GLP-1R agonist, exerts anti-diabetic effects by stimulating insulin secretion.
  • Journal: Molecular and Cellular Endocrinology
  • Date: 2023-07-24
  • Authors: Shang J, Yan W, Cui X, Ma W, Wang Z, Liu N, Yi X, Guo T, Wei X, Sun Y et al.